Renal safety and extrahepatic defluorination of sevoflurane in hepatic transplantations


Kanbak M., Karagoz A. H. , Erdem N., Oc B., Saricaoglu F., Ertas N. , ...Daha Fazla

TRANSPLANTATION PROCEEDINGS, cilt.39, sa.5, ss.1544-1548, 2007 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 39 Konu: 5
  • Basım Tarihi: 2007
  • Doi Numarası: 10.1016/j.transproceed.2007.01.081
  • Dergi Adı: TRANSPLANTATION PROCEEDINGS
  • Sayfa Sayıları: ss.1544-1548

Özet

Background. The main metabolic pathway for defluorination of sevoflurane in the liver produces inorganic fluoride (171). The metabolism and effect of sevoflurane on the kidney is not clear during anhepatic phase in liver transplantation. The goal of the present study was to investigate the metabolism and renal effect of sevoflurane by measuring plasma and urine inorganic fluoride, urinary N-acetyl-glucosaminidase (NAG), and plasma creatinine levels in patients undergoing liver transplantations.